Cargando…
Dual-targeted magnetic mesoporous silica nanoparticles reduce brain amyloid-β burden via depolymerization and intestinal metabolism
Rationale: Active removal of excess peripheral amyloid-β (Aβ) can potentially treat Alzheimer's disease (AD). However, the peripheral clearance of Aβ using an anti-Aβ monoclonal antibody (mAb) cannot remove PET-detectable Aβ within the brain. This may be due to the inability of mAb to cross the...
Autores principales: | Liu, Ni, Liang, Xiaohan, Yang, Changwen, Hu, Shun, Luo, Qingming, Luo, Haiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516238/ https://www.ncbi.nlm.nih.gov/pubmed/36185606 http://dx.doi.org/10.7150/thno.76574 |
Ejemplares similares
-
Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
por: Liu, Ni, et al.
Publicado: (2022) -
Dynamic Changes in the Levels of Amyloid-β(42) Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease
por: Zhang, Liding, et al.
Publicado: (2021) -
Hyaluronidase-Responsive Mesoporous Silica Nanoparticles with Dual-Imaging and Dual-Target Function
por: Wu, Zhi-Yuan, et al.
Publicado: (2019) -
In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles
por: Chen, Feng, et al.
Publicado: (2015) -
Biosafety of Mesoporous Silica Nanoparticles
por: Rascol, Estelle, et al.
Publicado: (2018)